Anlotinib Hydrochloride: Drug: Anlotinib Hydrochloride Anlotinib hydrochloride will be given with a daily dose of 12 mg for 14 days of a 21-day cycle up to 2 cycles, initiated on the first day of radiation therapy and followed by adjuvant treatment with the same dosing schedule until patients have disease progression or intolerable toxicities.
Placebo: Drug: Placebo Placebo will be given with a daily dose of 12 mg for 14 days of a 21-day cycle up to 2 cycles, initiated on the first day of radiation therapy and followed by adjuvant treatment with the same dosing schedule until patients have disease progression or intolerable toxicities.
Radiation Therapy: Radiation: Radiation therapy Radiation therapy will be delivered in daily fractions of 1.8-2.0 Gy given 5 days a week for a total of 54-60 Gy.
Temozolomide: Drug: Temozolomide Temozolomide will be administered at a daily dose of 75 mg/m2 until the completion of radiation therapy. Four weeks after the completion of radiation therapy, patients will be given with adjuvant chemotherapy with temozolomide at a dose of 200 mg/m2 for 5 days of a 28-day cycle for a total of 6 cycles.
Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma.Take PFS as the main evaluation index, the purpose is to evaluate its effectiveness
| Facility | City | Region | Status |
|---|---|---|---|
| The First Affiliated Hospital of Bengbu Medical College | Bengbu | Anhui | |
| Beijing TianTan Hospital,Capital Medical University | Beijing | Beijing Municipality | |
| The Sixth Madical Center of PLA General Hospital | Beijing | Beijing Municipality | |
| The General Hospital of the People's Liberation Army (PLAGH) | Beijing | Beijing Municipality | |
| Chongqing University Cancer Hospital | Chongqing | Chongqing Municipality | |
| Fujian Provincial Cancer Hospital | Fuzhou | Fujian | |
| Lanzhou University Second Hospital | Lanzhou | Gansu | |
| The First Hospital of Lanzhou University | Lanzhou | Gansu | |
| Sun Yat-sen University Cancer Center | Guangzhou | Guangdong | |
| Shenzhen People's Hospital | Shenzhen | Guangdong | |
| The Fifth Affiliated Hospital Sun Yat-sen University | Zhuhai | Guangdong | |
| Henan Cancer Hospital | Zhengzhou | Henan | |
| The affiliated hospital of xuzhou medical university | Xuzhou | Jiangsu | |
| The First Affiliated Hospital of NanChang University | Nanchang | Jiangxi | |
| Jiangxi Cancer Hospital | Nanchang | Jiangxi | |
| Gansu Provincial Hospital | Gansu | Lanzhou Province | |
| Liaoning Cancer Hospital & Institute | Shenyang | Liaoning | |
| Fudan University shabghai cancer center | Shanghai | Shanghai Municipality | |
| The Second Affiliated Hospital of PLA Air Force Medical University | Xian | Shanxi | |
| West China Hospital,Sichuan University | Chengdu | Sichuan | |
| Tianjin Medical University General Hospital | Tianjin | Tianjin Municipality | |
| Zhejiang Cancer Hospital | Hangzhou | Zhejiang |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04959500 on ClinicalTrials.gov ↗ ← All trials in China